InvestSMART

AFT Pharmaceuticals Limited (ASX: AFP) - Announcements

Current share price for AFP : $3.650 0.05 (1.39%)+

ASX company news and announcements for AFT Pharmaceuticals Limited (AFP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All AFT Pharmaceuticals Limited (AFP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than AFT Pharmaceuticals Limited (AFP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for AFT Pharmaceuticals Limited (AFP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$383 AFT to release FY26 results 12 May 2026 7:30AM $3.190 $3.650 risen by 14.42%
$383 March Quarter FY 2026 Investor Update 7 Apr 2026 7:30AM $2.730 $3.650 risen by 33.70%
$383 Chief Financial Officer update 24 Mar 2026 10:47AM $2.730 $3.650 risen by 33.70%
$383 Court of Appeal dismisses PBL Port Wine Stain profit claim 9 Mar 2026 7:40AM $3.100 $3.650 risen by 17.74%
$383 December Quarter FY 2026 Investor Update 15 Jan 2026 7:30AM $2.970 $3.650 risen by 22.90%
$383 FY26 Interim presentation 20 Nov 2025 7:31AM $2.710 $3.650 risen by 34.69%
$383 FY26 Interim Report 20 Nov 2025 7:31AM $2.710 $3.650 risen by 34.69%
$383 FY26 Interim release 20 Nov 2025 7:31AM $2.710 $3.650 risen by 34.69%
$383 AFT CFO Malcolm Tubby to retire Simon Bosley CFO Designate 19 Nov 2025 7:32AM $2.710 $3.650 risen by 34.69%
$383 AFT to announce half year interim results Nov 20 24 Oct 2025 8:11AM $2.610 $3.650 risen by 39.85%
$383 September Quarter FY2026 Investor Update 25 Sep 2025 7:31AM $2.300 $3.650 risen by 58.70%
$383 Disclosure of Directors and Senior Managers Relevant Interes 1 Sep 2025 3:18PM $2.300 $3.650 risen by 58.70%
$383 Results of 2025 Annual Shareholder Meeting 4 Aug 2025 12:44PM $2.400 $3.650 risen by 52.08%
$383 AFT ASM Presentation 1 Aug 2025 7:30AM $2.400 $3.650 risen by 52.08%
$383 AFT ASM Chairs Speech 1 Aug 2025 7:30AM $2.400 $3.650 risen by 52.08%
$383 AFT ASM Release 1 Aug 2025 7:30AM $2.400 $3.650 risen by 52.08%
$383 Disclosure of Directors and Senior Managers Relevant Interes 4 Jul 2025 7:30AM $2.590 $3.650 risen by 40.93%
$383 June Quarter FY 2026 Investor Update 1 Jul 2025 7:31AM $2.430 $3.650 risen by 50.21%
$383 Disclosure of Directors and Senior Managers Relevant Interes 27 Jun 2025 7:31AM $2.270 $3.650 risen by 60.79%
$383 Notice of Annual Meeting of Shareholders 2025 27 Jun 2025 7:30AM $2.270 $3.650 risen by 60.79%
$383 Update - Dividend/Distribution - AFP 24 Jun 2025 3:04PM $2.270 $3.650 risen by 60.79%
$383 Update - Dividend/Distribution - AFP 24 Jun 2025 10:00AM $2.260 $3.650 risen by 61.50%
$383 AFT and Hikma extend US Maxigesic Cooperation 26 May 2025 10:06AM $2.450 $3.650 risen by 48.98%
$383 Dividend/Distribution - AFP 23 May 2025 3:10PM $2.450 $3.650 risen by 48.98%
$383 FY2025 Distribution Notice correction 22 May 2025 12:16PM $2.450 $3.650 risen by 48.98%

26 - 50 of 546 results

Page 2 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.